Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Covington
Merck
QuintilesIMS
Julphar
UBS
Healthtrust
Harvard Business School
Accenture

Generated: January 21, 2018

DrugPatentWatch Database Preview

TENATHAN Drug Profile

« Back to Dashboard

When do Tenathan patents expire, and when can generic versions of Tenathan launch?

Tenathan is a drug marketed by Robins Ah and is included in one NDA.

The generic ingredient in TENATHAN is bethanidine sulfate. Additional details are available on the bethanidine sulfate profile page.
Summary for TENATHAN
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 21
Patent Applications: 425
Drug Prices:see details
DailyMed Link:TENATHAN at DailyMed
Drug patent expirations by year for TENATHAN
Medical Subject Heading (MeSH) Categories for TENATHAN

US Patents and Regulatory Information for TENATHAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Robins Ah TENATHAN bethanidine sulfate TABLET;ORAL 017675-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Robins Ah TENATHAN bethanidine sulfate TABLET;ORAL 017675-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TENATHAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Robins Ah TENATHAN bethanidine sulfate TABLET;ORAL 017675-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Robins Ah TENATHAN bethanidine sulfate TABLET;ORAL 017675-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Mallinckrodt
UBS
Express Scripts
Chinese Patent Office
Federal Trade Commission
Moodys
AstraZeneca
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot